Eleftha 440mg Injection
Eleftha 440mg Injection
Trastuzumab (440mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Eleftha 440mg Injection contains Trastuzumab 440mg, a monoclonal antibody used in targeted cancer therapy for HER2-positive cancers. It works by attaching to HER2 receptors on cancer cells and blocking signals that promote their growth and division. This targeted mechanism helps slow tumor progression and enhances the effectiveness of cancer treatment. Trastuzumab is commonly used in the management of HER2-positive breast cancer and certain types of gastric cancer under specialist supervision. When administered as directed by oncology professionals, Eleftha 440mg Injection helps support effective cancer management and improved treatment outcomes.
Active composition
Trastuzumab 440 mg
About Trastuzumab
Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer. It inhibits cancer cell growth and promotes cell death. Its clinical relevance lies in managing specific breast cancer types. In summary, Trastuzumab is essential for treating HER2-positive breast cancer.
How It Works
Trastuzumab binds to the HER2 receptor, inhibiting signaling pathways that promote cancer cell proliferation.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Eleftha 440mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Eleftha 440mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Eleftha 440mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Eleftha 440mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Eleftha 440mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Eleftha 440mg Injection in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Eleftha 440mg Injection
